Raptor Pharma (RPTP) CEO Won't Comment on Shire (SHPG) Bid Report, Calls it 'Rumor' - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Raptor Pharma's (NASDAQ: RPTP) CEO Julie Smith told Bloomberg in a phone interview that the company does not comment on "speculation or rumors." Earlier Intereconomia said Shire offered to acquire the company for $800 million.
"I would characterize it as a rumor," she reportedly said.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon Communications (VZ) To Acquire Vessel's Technology
- Parexel (PRXL) Misses Q1 EPS by 10c; Guides Below, Announces $200M Stock Buyback Plan
- St. Jude Medical (STJ) Shareholders Approve Abbott (ABT) Merger
Create E-mail Alert Related CategoriesManagement Comments, Mergers and Acquisitions, Rumors
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!